Victor S. Blanchette

27.2k total citations · 6 hit papers
305 papers, 18.2k citations indexed

About

Victor S. Blanchette is a scholar working on Hematology, Genetics and Genetics. According to data from OpenAlex, Victor S. Blanchette has authored 305 papers receiving a total of 18.2k indexed citations (citations by other indexed papers that have themselves been cited), including 273 papers in Hematology, 63 papers in Genetics and 32 papers in Genetics. Recurrent topics in Victor S. Blanchette's work include Platelet Disorders and Treatments (153 papers), Hemophilia Treatment and Research (150 papers) and Blood groups and transfusion (86 papers). Victor S. Blanchette is often cited by papers focused on Platelet Disorders and Treatments (153 papers), Hemophilia Treatment and Research (150 papers) and Blood groups and transfusion (86 papers). Victor S. Blanchette collaborates with scholars based in Canada, United States and United Kingdom. Victor S. Blanchette's co-authors include Shoshana Revel‐Vilk, Peter N. Cox, Nancy Robitaille, Douglas B. Cines, Kathelijn Fischer, John G. Kelton, G. Rock, Kenneth H. Shumak, Manuel Carção and Rashmi Ravindran Nair and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Victor S. Blanchette

301 papers receiving 17.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hematological Problems in Pediatric Intensive Care

2013 3.0k citations Shoshana Revel‐Vilk, Victor S. Blanchette et al. profile →
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

2008 1.9k citations James B. Bussel, Paul Imbach et al. Blood profile →
Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura

1991 1.3k citations Victor S. Blanchette et al. profile →
Immune Thrombocytopenic Purpura

2002 988 citations Victor S. Blanchette et al. profile →
Definitions in hemophilia: communication from the SSC of the ISTH

2014 528 citations Victor S. Blanchette, Alok Srivastava et al. profile →
Haemophilia

2021 178 citations Victor S. Blanchette et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Victor S. Blanchette Canada	57	14.1k	3.2k	3.2k	2.0k	1.6k	305	18.2k
James B. Bussel United States	73	17.2k 1.2×	3.8k 1.2×	3.4k 1.1×	2.4k 1.2×	1.6k 1.0×	514	21.1k
James N. George United States	63	11.1k 0.8×	7.6k 2.4×	3.5k 1.1×	1.8k 0.9×	4.5k 2.8×	296	17.1k
Jeff Szer Australia	58	8.4k 0.6×	4.8k 1.5×	3.2k 1.0×	706 0.4×	1.6k 1.0×	385	15.3k
Flora Peyvandi Italy	65	10.7k 0.8×	4.3k 1.4×	3.7k 1.2×	1.4k 0.7×	2.0k 1.3×	652	18.3k
Ingrid Pabinger Austria	73	10.5k 0.7×	1.4k 0.4×	2.4k 0.8×	2.5k 1.2×	456 0.3×	541	20.3k
Gèrard Socié France	91	18.7k 1.3×	9.2k 2.9×	4.8k 1.5×	2.0k 1.0×	1.8k 1.1×	701	30.2k
John G. Kelton Canada	66	9.2k 0.7×	2.5k 0.8×	1.4k 0.5×	7.6k 3.8×	1.5k 1.0×	236	16.3k
Jakob Passweg Switzerland	72	13.3k 0.9×	4.7k 1.5×	5.5k 1.7×	1.3k 0.7×	315 0.2×	497	21.0k
Aloïs Gratwohl Switzerland	80	17.1k 1.2×	5.7k 1.8×	4.8k 1.5×	1.1k 0.6×	362 0.2×	515	23.8k
Beverley J. Hunt United Kingdom	65	5.7k 0.4×	2.2k 0.7×	1.3k 0.4×	4.7k 2.4×	1.5k 0.9×	340	19.3k

Countries citing papers authored by Victor S. Blanchette

Since Specialization

Citations

This map shows the geographic impact of Victor S. Blanchette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor S. Blanchette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor S. Blanchette more than expected).

Fields of papers citing papers by Victor S. Blanchette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor S. Blanchette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor S. Blanchette. The network helps show where Victor S. Blanchette may publish in the future.

Co-authorship network of co-authors of Victor S. Blanchette

This figure shows the co-authorship network connecting the top 25 collaborators of Victor S. Blanchette. A scholar is included among the top collaborators of Victor S. Blanchette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor S. Blanchette. Victor S. Blanchette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Panwar, Jyoti, Arun Mohanta, Pamela Hilliard, et al.. (2025). Evaluation of Point‐of‐Care Ultrasound in Paediatric Haemophilic Arthropathy: A Prospective Comparative Study With Comprehensive Ultrasound and MRI. Haemophilia. 31(4). 787–798.

Young, Nancy L., et al.. (2024). Face validity of the Kids’ ITP Tools (KIT) in the era of thrombopoietin receptor agonists. Pediatric Blood & Cancer. 71(4). e30888–e30888. 2 indexed citations

Wu, Runhui, Xiaojing Li, Qing Zhang, et al.. (2021). Significant reduction in hemarthrosis in boys with severe hemophilia A: The China hemophilia individualized low‐dose secondary prophylaxis study. Research and Practice in Thrombosis and Haemostasis. 5(6). e12552–e12552. 8 indexed citations

Tolend, Mirkamal, Haris Majeed, Marcelo Bordalo Rodrigues, et al.. (2020). Critical appraisal of the International Prophylaxis Study Group magnetic resonance image scale for evaluating haemophilic arthropathy. Haemophilia. 26(4). 565–574. 10 indexed citations

Blanchette, Victor S., David Lillicrap, Shannon Jackson, et al.. (2018). A Practical, One Clinic Visit, Population Pharmacokinetic (PK) Protocol for Generation of PK Profiles in Subjects with Severe Hemophilia a. Blood. 132(Supplement 1). 2480–2480. 1 indexed citations

Abadeh, Armin, et al.. (2017). A systematic review of ultrasound imaging as a tool for evaluating haemophilic arthropathy in children and adults. Haemophilia. 23(4). 598–612. 24 indexed citations

Oldenburg, Johannes, Roshni Kulkarni, Alok Srivastava, et al.. (2017). Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein. Haemophilia. 24(1). 77–84. 38 indexed citations

Tarantino, Michael D., James B. Bussel, Victor S. Blanchette, et al.. (2016). Final Safety and Efficacy Data of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP). Blood. 130(22). 14–14. 2 indexed citations

Labarque, Veerle, et al.. (2016). The Factor VIII to Von Willebrand Factor Antigen (FVIII/VWF:Ag) ratio could be helpful in identifying carriers of hemophilia A. Haemophilia. 22(4). 16. 1 indexed citations

10.

Abrahamyan, Lusine, Andrew R. Willan, Joseph Beyene, et al.. (2014). Using Value-of-Information Methods when the Disease Is Rare and the Treatment Is Expensive—The Example of Hemophilia A. Journal of General Internal Medicine. 29(S3). 767–773. 12 indexed citations

11.

Bussel, James B., George R. Buchanan, Diane J. Nugent, et al.. (2011). A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia. Blood. 118(1). 28–36. 157 indexed citations

12.

Biss, Tina, et al.. (2008). The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey. Haemophilia. 14(5). 923–930. 71 indexed citations

13.

Klaassen, Robert J., Victor S. Blanchette, Dorothy Barnard, et al.. (2007). Validity, Reliability, and Responsiveness of a New Measure of Health-Related Quality of Life in Children with Immune Thrombocytopenic Purpura: The Kids’ ITP Tools. The Journal of Pediatrics. 150(5). 510–515.e1. 64 indexed citations

14.

Young, Nancy L., Catharine S. Bradley, Cindy Wakefield, et al.. (2005). How well does the Canadian haemophilia Outcomes‐Kids' Life Assessment Tool (CHO‐KLAT) measure the quality of life of boys with haemophilia?. Pediatric Blood & Cancer. 47(3). 305–311. 57 indexed citations

15.

Barnard, Dorothy, David Feeny, Patricia McCusker, et al.. (2003). Development of Disease-Specific Health-Related Quality-of-Life Instruments for Children With Immune Thrombocytopenic Purpura and Their Parents. Journal of Pediatric Hematology/Oncology. 25(1). 56–62. 44 indexed citations

16.

Manco‐Johnson, M. J. & Victor S. Blanchette. (2003). North American prophylaxis studies for persons with severe haemophilia: background, rationale and design. Haemophilia. 9(s1). 44–49. 26 indexed citations

17.

Revel‐Vilk, Shoshana, et al.. (2002). DDAVP challenge tests in boys with mild/moderate haemophilia A*. British Journal of Haematology. 117(4). 947–951. 29 indexed citations

18.

Sotelo‐Avila, Cirilo, Maria Albanese, Heather Hume, et al.. (1993). National Survey of Neonatal Transfusion Practices: II. Blood Component Therapy. PEDIATRICS. 91(3). 530–536. 48 indexed citations

19.

Jenkin, Derek, John Doyle, Martin Berry, et al.. (1990). Hodgkin's disease in children: Treatment with MOPP and low‐dose, extended field irradiation without laparotomy late results and toxicity. Medical and Pediatric Oncology. 18(4). 265–272. 36 indexed citations

20.

Blanchette, Victor S., R. A. Sacher, Penny Ballem, J B Bussel, & Paul Imbach. (1989). Commentary on the management of autoimmune thrombocytopenia during pregnancy and in the neonatal period. Annals of Hematology. 59(1). 121–123. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact